16:13 EDT Iovance Biotherapeutics files automatic mixed securities shelf
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on IOVA:
- Iovance announces first patient randomized in Phase 3 TILVANCE-301 trial
- Iovance Biotherapeutics Announces First Patient Randomized in Phase 3 TILVANCE-301 Trial in Frontline Advanced Melanoma
- Iovance Biotherapeutics to Present at Jefferies Global Healthcare Conference
- Biotech Alert: Searches spiking for these stocks today
- Iovance Surges after U.S. FDA Approval for Lifileucel